A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome.

Saved in:
Bibliographic Details
Title: A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome.
Authors: Mokhtare M; Gastroenterology and Hepatology, Internal Medicine Department, School of Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Niyayesh St., Sattarkhan Ave., Tehran, Iran. marjanmokhtare@yahoo.com., Fathi M; Gastroenterology and Hepatology, Internal Medicine Department, School of Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Niyayesh St., Sattarkhan Ave., Tehran, Iran., Sadeghian AM; School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Sotoudeheian MJ; Physiology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran., Namazi A; Gastroenterology and Hepatology, Internal Medicine Department, School of Medicine, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Niyayesh St., Sattarkhan Ave., Tehran, Iran.
Source: Clinical drug investigation [Clin Drug Investig] 2024 Nov; Vol. 44 (11), pp. 839-847. Date of Electronic Publication: 2024 Oct 30.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1918
DOI:10.1007/s40261-024-01403-w